Skip to main content

Advertisement

Log in

Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Helios belongs to Ikaros family, which plays an important role in the cell-fate decision and control cell proliferation; abnormal expressions in leukemia are associated with poor prognosis. In this study, we investigated the Helios expression between Helicobacter pylori infection and prognosis in gastric cancer patients.

Methods

A total of 67 gastric cancer patients who received partial or full gastrectomies were enrolled. Helios expression by immunohistochemistry and mRNA was investigated with the clinical stage, Helicobacter pylori infection, CD4 expression, FoxP3 expression and prognosis.

Results

From the immunohistochemistry stain, we found that the Helios was expressed in both cancer cell and tumor-infiltrated lymphocytes. The high expression of Helios in gastric tumor cells had a better median overall survival rate in gastric cancer patients (50.7 ± 3.2 vs. 34.1 ± 4.9 months; P = 0.015), Helicobacter pylori-infected patients (51.1 ± 3.5 vs. 30.4 ± 5.1 months; P = 0.007) and advanced gastric cancer patients (42.1 ± 5.5 vs. 23.2 ± 4.8 months; P = 0.043). From multivariate analysis, the Helios expression in gastric tumor cells was an independent factor to predict better survival in all gastric cancers (HR = 2.78; 95 % confidence interval [CI], 1.09–7.09; P = 0.032) and advanced gastric cancer patients (HR = 2.85; 95 % confidence interval [CI], 1.00–8.13; P = 0.03).

Conclusions

Higher expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients, especially for Helicobacter pylori-infected and advanced-stage gastric cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Abe A, Nagatsuma AK, Higuchi Y, Nakamura Y, Yanagihara K, Ochiai A (2015) Site-specific fibroblasts regulate sitespecific inflammatory niche formation in gastric cancer. Gastric Cancer. doi:10.1007/s10120-015-0584-y

    Google Scholar 

  • Asanuma S, Yamagishi M, Kawanami K, Nakano K, Sato-Otsubo A, Muto S et al (2013) Adult T-cell leukemia cells are characterized by abnormalities of Helios expression that promote T cell growth. Cancer Sci 104:1097–1106

    Article  CAS  PubMed  Google Scholar 

  • Baine IU, Basu S, Ames R, Sellers RS, Macian F (2013) Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. J Immunol 190:1008–1016

    Article  CAS  PubMed  Google Scholar 

  • Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252–7259

    Article  CAS  PubMed  Google Scholar 

  • Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209

    Article  Google Scholar 

  • Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, Braud AC et al (2004) Immunophenotypic analysis of inflammatory breast cancers: identification of an ‘inflammatory signature’. J Pathol 202:265–273

    Article  PubMed  Google Scholar 

  • deLeeuw RJ, Kost SE, Kakal JA, Nelson BH (2012) The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res 18:3022–3029

    Article  CAS  PubMed  Google Scholar 

  • Dovat S, Montecino-Rodriguez E, Schuman V, Teitell MA, Dorshkind K, Smale ST (2005) Transgenic expression of Helios in B lineage cells alters B cell properties and promotes lymphomagenesis. J Immunol 175:3508–3515

    Article  CAS  PubMed  Google Scholar 

  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2012) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int J Cancer 136:E359–E386

    Article  Google Scholar 

  • Fujii K, Ishimaru F, Nakase K, Tabayashi T, Kozuka T, Naoki K et al (2003) Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma. Br J Haematol 120:986–989

    Article  CAS  PubMed  Google Scholar 

  • Georgopoulos K (2002) Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2:162–174

    Article  CAS  PubMed  Google Scholar 

  • Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen HR, Bruno TC et al (2010) A role for the transcription factor Helios in human CD4[+]CD25[+] regulatory T cells. Mol Immunol 47:1595–1600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hahm K, Cobb BS, McCarty AS, Brown KE, Klug CA, Lee R et al (1998) Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev 12:782–796

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061

    Article  CAS  PubMed  Google Scholar 

  • John LB, Ward AC (2011) The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 48:1272–1278

    Article  CAS  PubMed  Google Scholar 

  • Kashimura S, Saze Z, Terashima M, Soeta N, Ohtani S, Osuka F et al (2012) CD83[+] dendritic cells and Foxp3[+] regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Gastric Cancer 15:144–153

    Article  CAS  PubMed  Google Scholar 

  • Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J et al (2015) Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet 47:1304–1315

    Article  CAS  PubMed  Google Scholar 

  • Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, Georgopoulos K et al (1998) Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol 8:508–515

    Article  CAS  PubMed  Google Scholar 

  • Kim KJ, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH et al (2014) Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Hum Pathol 45:285–293

    Article  CAS  PubMed  Google Scholar 

  • Kindlund B, Sjoling A, Yakkala C, Adamsson J, Janzon A, Hansson LE et al (2016) CD4 regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-beta. Gastric Cancer. doi:10.1007/s10120-015-0591-z

    PubMed  Google Scholar 

  • Martin-Ibanez R, Crespo E, Esgleas M, Urban N, Wang B, Waclaw R et al (2012) Helios transcription factor expression depends on Gsx2 and Dlx1&2 function in developing striatal matrix neurons. Stem Cells Dev 21:2239–2251

    Article  CAS  PubMed  Google Scholar 

  • Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB et al (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360:470–480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, Park SR et al (2011) Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 29:3968–3976

    Article  CAS  PubMed  Google Scholar 

  • Rebollo A, Schmitt C (2003) Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol Cell Biol 81:171–175

    Article  CAS  PubMed  Google Scholar 

  • Shang B, Liu Y, Jiang SJ, Liu Y (2015) Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep 5:15179

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takatori H, Kawashima H, Matsuki A, Meguro K, Tanaka S, Iwamoto T et al (2015) Helios enhances Treg cell function in cooperation with FoxP3. Arthritis Rheumatol 67:1491–1502

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Chang Gung Memorial Hospital, Chiayi (Taiwan, Republic of China). We thank the Laboratory Animal Center, Department of Medical Research, Chang Gung Memorial Hospital at Chiayi; Tissue Bank, Department of Medical Research, Chang Gung Memorial Hospital at Chiayi; the EVERBIO AutoTiss 1000 tissue microarrayer service provided by the Expensive Advanced Instrument Core Laboratory, Department of Medical Research and Development, Chang Gung Memorial Hospital at Chiayi to help us in the experiments and tissue collection.

Funding

This study was funded by Chang Gung Memorial Hospital, Chia-Yi, TW. The funding number is CORPG6D0011, CORPG6D0012, CORPG6D0013, CORPG6D0021, CORPG6D0022, CORPG6D0023.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shu-Fen Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights statement

The Institutional Review Board of the Chang Gung Memorial Hospital approved all human subject assessments (IRB No. 104-4187C).

Informed consent

The pathologic examination and further investigation were carried out under the informed consent of the patients.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, WM., Wu, CS., Liu, JL. et al. Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients. J Cancer Res Clin Oncol 142, 2375–2382 (2016). https://doi.org/10.1007/s00432-016-2223-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-016-2223-3

Keywords

Navigation